Nutrien (NTR) Misses Q4 EPS by 29cl revises guidance

Nutrien (NYSE: NTR) reported Q4 EPS of $0.37, $0.29 worse than the analyst estimate of $0.66. Revenue for the quarter came in at $5.66 billion versus the consensus estimate of $5.36 billion.

GUIDANCE

We have revised our guidance practice in 2024 to provide forward looking estimates on those metrics that we believe are of value to our shareholders and are less impacted by fertilizer commodity prices. We continue to provide guidance for Retail adjusted EBITDA, fertilizer sales volumes and other key financial modeling metrics as well as fertilizer pricing sensitivities.

Retail adjusted EBITDA guidance of $1.65 to $1.85 billion assumes increased gross margins in all major product lines compared to 2023.

Total capital expenditures of $2.2 to $2.3 billion are expected to be below the prior year.

For earnings history and earnings-related data on Nutrien (NTR) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• CrowdStrike posts record ARR growth, raises full-year outlook
• Petco Health and Wellness (WOOF) Misses Q1 EPS by 6c